NASDAQ:RPRX

Royalty Pharma Stock Insider Trading

Healthcare > Biotechnology

Buy RPRX

*Your capital is at risk

$54.97

+0.96 (+1.78%)

At Close: Jun 03, 2026

Royalty Pharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -64.66. In total, the insiders bought 1.73M and sold 1.78M RPRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-64.66
● Buy	1.73M shares
● Sell	1.78M shares
29% Buy Activity Moderate Negative Correlation
Sell Signal High Confidence May 26, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -64.66. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 26, 2026 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	64 399 Value: $3.48M
May 20, 2026 Sell	Class A Ordinary Shares S-Sale	Urist Marshall EVP, Research & Investments	Officer	13 684 Value: $721.8K
May 14, 2026 Sell	Class A Ordinary Shares S-Sale	Norden Gregory Director	Director	3 045 Value: $161.4K
May 14, 2026 Sell	Class A Ordinary Shares S-Sale	Urist Marshall EVP, Research & Investments	Officer	13 684 Value: $726.1K
May 06, 2026 Buy	Class A Ordinary Shares A-Award	Urist Marshall EVP, Research & Investments	Officer	18 197 Value: $923.0K
May 06, 2026 Buy	Class A Ordinary Shares A-Award	Hite Christopher EVP & Vice Chairman	CEO / President	24 263 Value: $1.23M
May 06, 2026 Buy	Class A Ordinary Shares A-Award	Coyne Terrance P. EVP & CFO	C-Suite Officer	24 263 Value: $1.23M
May 06, 2026 Buy	Class A Ordinary Shares A-Award	Legorreta Pablo G. CEO, Chairman Of The Board	CEO / President	143 821 Value: $7.29M
Apr 28, 2026 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	1 875 Value: $93.3K
Apr 28, 2026 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	32 916 Value: $1.64M
Apr 01, 2026 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	1 875 Value: $90.6K
Apr 01, 2026 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	32 916 Value: $1.59M
Mar 31, 2026 Buy	Class A Ordinary Shares A-Award	Bassler Bonnie L Director	Director	815 Value: $37.5K
Mar 23, 2026 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	32 916 Value: $1.50M
Mar 23, 2026 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	1 875 Value: $85.4K
Mar 02, 2026 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	583 Value: $27.4K
Mar 02, 2026 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	1 292 Value: $60.3K
Mar 02, 2026 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	22 487 Value: $1.05M
Mar 02, 2026 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	10 429 Value: $490.3K
Feb 23, 2026 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	1 875 Value: $85.0K
Feb 23, 2026 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	32 916 Value: $1.49M
Feb 11, 2026 Buy	Class A Ordinary Shares A-Award	Urist Marshall EVP, Research & Investments	Officer	19 970 Value: $883.7K
Feb 11, 2026 Buy	Class A Ordinary Shares A-Award	Hite Christopher EVP & Vice Chairman	CEO / President	26 626 Value: $1.18M
Feb 11, 2026 Buy	Class A Ordinary Shares A-Award	Coyne Terrance P. EVP & CFO	C-Suite Officer	26 626 Value: $1.18M
Feb 11, 2026 Buy	Class A Ordinary Shares A-Award	Legorreta Pablo G. CEO, Chairman Of The Board	CEO / President	157 828 Value: $6.98M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ROYALTY PHARMA PLC

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pha...

Read Full Profile Here